Literature DB >> 26395760

Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells.

Hao Bai1, Yanfeng Liu1, Yinliang Xie2, Dixie L Hoyle1, Robert A Brodsky1, Linzhao Cheng1, Tao Cheng2, Zack Z Wang1.   

Abstract

Generation of fully functional hematopoietic multipotent progenitor (MPP) cells from human pluripotent stem cells (hPSCs) has a great therapeutic potential to provide an unlimited cell source for treatment of hematological disorders. We previously demonstrated that CD34(+) CD31(+) CD144(+) population derived from hPSCs contain hemato-endothelial progenitors (HEPs) that give rise to hematopoietic and endothelial cells. Here, we report a differentiation system to generate definitive hematopoietic MPP cells from HEPs via endothelial monolayer. In the presence of angiogenic factors, HEPs formed an endothelial monolayer, from which hematopoietic clusters emerged through the process of endothelial-to-hematopoietic transition (EHT). EHT was significantly enhanced by hematopoietic growth factors. The definitive MPP cells generated from endothelial monolayer were capable of forming multilineage hematopoietic colonies, giving rise to T lymphoid cells, and differentiating into enucleated erythrocytes. Emergence of hematopoietic cells from endothelial monolayer occurred transiently. Hematopoietic potential was lost during prolonged culture of HEPs in endothelial growth conditions. Our study demonstrated that CD34(+) CD31(+) CD144(+) HEPs gave rise to hematopoietic MPP cells via hemogenic endothelial cells that exist transiently. The established differentiation system provides a platform for future investigation of regulatory factors involved in de novo generation of hematopoietic MPP cells and their applications in transplantation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26395760      PMCID: PMC4729203          DOI: 10.1002/jcp.25199

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  42 in total

1.  Live imaging of Runx1 expression in the dorsal aorta tracks the emergence of blood progenitors from endothelial cells.

Authors:  Enid Yi Ni Lam; Christopher J Hall; Philip S Crosier; Kathryn E Crosier; Maria Vega Flores
Journal:  Blood       Date:  2010-05-07       Impact factor: 22.113

2.  RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Authors:  Dan Ran; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

3.  Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro.

Authors:  Tong Chen; Hao Bai; Ying Shao; Melanie Arzigian; Viktor Janzen; Eyal Attar; Yi Xie; David T Scadden; Zack Z Wang
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

4.  Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro.

Authors:  Georges Lacaud; Lia Gore; Marion Kennedy; Valerie Kouskoff; Paul Kingsley; Christopher Hogan; Leif Carlsson; Nancy Speck; James Palis; Gordon Keller
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

5.  Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium.

Authors:  Ben Van Handel; Amélie Montel-Hagen; Rajkumar Sasidharan; Haruko Nakano; Roberto Ferrari; Cornelis J Boogerd; Johann Schredelseker; Yanling Wang; Sean Hunter; Tõnis Org; Jian Zhou; Xinmin Li; Matteo Pellegrini; Jau-Nian Chen; Stuart H Orkin; Siavash K Kurdistani; Sylvia M Evans; Atsushi Nakano; Hanna K A Mikkola
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

6.  Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.

Authors:  Ying Wang; Bin-Kuan Chou; Sarah Dowey; Chaoxia He; Sharon Gerecht; Linzhao Cheng
Journal:  Stem Cell Res       Date:  2013-08-09       Impact factor: 2.020

7.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.

Authors:  Bin-Kuan Chou; Prashant Mali; Xiaosong Huang; Zhaohui Ye; Sarah N Dowey; Linda Ms Resar; Chunlin Zou; Y Alex Zhang; Jay Tong; Linzhao Cheng
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

8.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962

Review 9.  Primitive and definitive erythropoiesis in mammals.

Authors:  James Palis
Journal:  Front Physiol       Date:  2014-01-28       Impact factor: 4.566

10.  Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells.

Authors:  Christopher M Sturgeon; Andrea Ditadi; Geneve Awong; Marion Kennedy; Gordon Keller
Journal:  Nat Biotechnol       Date:  2014-05-18       Impact factor: 54.908

View more
  8 in total

1.  Defining early hematopoietic-fated primitive streak specification of human pluripotent stem cells by the orchestrated balance of Wnt, activin, and BMP signaling.

Authors:  Jun Shen; Cuicui Lyu; Yaoyao Zhu; Zicen Feng; Shuo Zhang; Dixie L Hoyle; Guangzhen Ji; Robert A Brodsky; Tao Cheng; Zack Z Wang
Journal:  J Cell Physiol       Date:  2019-02-10       Impact factor: 6.384

2.  Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.

Authors:  Mathew G Angelos; Paige N Ruh; Beau R Webber; Robert H Blum; Caitlin D Ryan; Laura Bendzick; Seonhui Shim; Ashley M Yingst; Dejene M Tufa; Michael R Verneris; Dan S Kaufman
Journal:  Blood       Date:  2017-05-22       Impact factor: 22.113

3.  Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1.

Authors:  Felipe Troncoso; Jesenia Acurio; Kurt Herlitz; Claudio Aguayo; Patricio Bertoglia; Enrique Guzman-Gutierrez; Marco Loyola; Marcelo Gonzalez; Meriem Rezgaoui; Gernot Desoye; Carlos Escudero
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

4.  Suppression of Transforming Growth Factor-β Signaling Delays Cellular Senescence and Preserves the Function of Endothelial Cells Derived from Human Pluripotent Stem Cells.

Authors:  Hao Bai; Yongxing Gao; Dixie L Hoyle; Tao Cheng; Zack Z Wang
Journal:  Stem Cells Transl Med       Date:  2016-09-20       Impact factor: 6.940

5.  Vitronectin-activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells.

Authors:  Jun Shen; Yaoyao Zhu; Shuo Zhang; Shuzhen Lyu; Cuicui Lyu; Zicen Feng; Dixie L Hoyle; Zack Z Wang; Tao Cheng
Journal:  Cell Prolif       Date:  2021-03-03       Impact factor: 6.831

6.  Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model.

Authors:  Nungruthai Nilsri; Panchalee Jangprasert; Jaturawat Pawinwongchai; Nipan Israsena; Ponlapat Rojnuckarin
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

7.  Generation of hematopoietic stem/progenitor cells with sickle cell mutation from induced pluripotent stem cell in serum-free system.

Authors:  Bárbara C M F Paes; Luiza C J R Stabeli; Péricles N M Costa; Maristela Delgado Orellana; Simone Kashima; Dimas Tadeu Covas; Virgínia Picanço-Castro
Journal:  Hematol Transfus Cell Ther       Date:  2020-03-06

8.  Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells.

Authors:  Ratchapong Netsrithong; Siriwal Suwanpitak; Bootsakorn Boonkaew; Kongtana Trakarnsanga; Lung-Ji Chang; Chartsiam Tipgomut; Chinnavuth Vatanashevanopakorn; Kovit Pattanapanyasat; Methichit Wattanapanitch
Journal:  Stem Cell Res Ther       Date:  2020-11-11       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.